Literature DB >> 11953750

Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways.

G E Hardingham1, Y Fukunaga, H Bading.   

Abstract

Here we report that synaptic and extrasynaptic NMDA (N-methyl-D-aspartate) receptors have opposite effects on CREB (cAMP response element binding protein) function, gene regulation and neuron survival. Calcium entry through synaptic NMDA receptors induced CREB activity and brain-derived neurotrophic factor (BDNF) gene expression as strongly as did stimulation of L-type calcium channels. In contrast, calcium entry through extrasynaptic NMDA receptors, triggered by bath glutamate exposure or hypoxic/ischemic conditions, activated a general and dominant CREB shut-off pathway that blocked induction of BDNF expression. Synaptic NMDA receptors have anti-apoptotic activity, whereas stimulation of extrasynaptic NMDA receptors caused loss of mitochondrial membrane potential (an early marker for glutamate-induced neuronal damage) and cell death. Specific blockade of extrasynaptic NMDA receptors may effectively prevent neuron loss following stroke and other neuropathological conditions associated with glutamate toxicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953750     DOI: 10.1038/nn835

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  607 in total

1.  Relationship between availability of NMDA receptor subunits and their expression at the synapse.

Authors:  Kate Prybylowski; Zhanyan Fu; Gabriele Losi; Lynda M Hawkins; JianHong Luo; Kai Chang; Robert J Wenthold; Stefano Vicini
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  Regulation of neuronal gene expression and survival by basal NMDA receptor activity: a role for histone deacetylase 4.

Authors:  Yelin Chen; Yuanyuan Wang; Zora Modrusan; Morgan Sheng; Joshua S Kaminker
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

3.  Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat.

Authors:  A H Shin; H J Kim; S A Thayer
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

4.  UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices.

Authors:  Min Xie; Shao-Hui Wang; Zhi-Min Lu; Ying Pan; Qi-Cai Chen; Xiao-Mei Liao
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

5.  Rit-mediated stress resistance involves a p38-mitogen- and stress-activated protein kinase 1 (MSK1)-dependent cAMP response element-binding protein (CREB) activation cascade.

Authors:  Geng-Xian Shi; Weikang Cai; Douglas A Andres
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

6.  Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.

Authors:  Clare M Gladding; Jing Fan; Lily Y J Zhang; Liang Wang; Jian Xu; Edward H Y Li; Paul J Lombroso; Lynn A Raymond
Journal:  J Neurochem       Date:  2014-04-02       Impact factor: 5.372

Review 7.  Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Authors:  Rui Wang; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Activity-dependent redistribution and essential role of cortactin in dendritic spine morphogenesis.

Authors:  Heike Hering; Morgan Sheng
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

9.  Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death.

Authors:  Brendan Lujan; Xiaoxuan Liu; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

Review 10.  Brain vulnerability and viability after ischaemia.

Authors:  Stefano G Daniele; Georg Trummer; Konstantin A Hossmann; Zvonimir Vrselja; Christoph Benk; Kevin T Gobeske; Domagoj Damjanovic; David Andrijevic; Jan-Steffen Pooth; David Dellal; Friedhelm Beyersdorf; Nenad Sestan
Journal:  Nat Rev Neurosci       Date:  2021-07-21       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.